0001385508-22-000012.txt : 20220105 0001385508-22-000012.hdr.sgml : 20220105 20220105162126 ACCESSION NUMBER: 0001385508-22-000012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220104 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Toole David D CENTRAL INDEX KEY: 0001491140 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38193 FILM NUMBER: 22511426 MAIL ADDRESS: STREET 1: 1640 MARENGO STREET CITY: LOS ANGELES STATE: CA ZIP: 90033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OPIANT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001385508 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 233 WILSHIRE BLVD, SUITE 280 STREET 2: SUITE 500 CITY: SANTA MONICA STATE: CA ZIP: 90401 BUSINESS PHONE: (310) 598-5410 MAIL ADDRESS: STREET 1: 233 WILSHIRE BLVD, SUITE 280 STREET 2: SUITE 500 CITY: SANTA MONICA STATE: CA ZIP: 90401 FORMER COMPANY: FORMER CONFORMED NAME: Lightlake Therapeutics Inc. DATE OF NAME CHANGE: 20091009 FORMER COMPANY: FORMER CONFORMED NAME: Madrona Ventures, Inc. DATE OF NAME CHANGE: 20070108 4 1 wf-form4_164141760647083.xml FORM 4 X0306 4 2022-01-04 0 0001385508 OPIANT PHARMACEUTICALS, INC. OPNT 0001491140 O'Toole David D C/O OPIANT PHARMACEUTICALS, INC. 233 WILSHIRE BOULEVARD, SUITE 280 SANTA MONICA CA 90401 0 1 0 0 Chief Financial Officer Common Stock 2022-01-04 4 A 0 12000 0 A 36015 D 12,000 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-third of the RSUs vest on the anniversary dates of January 4, 2023, January 4, 2024 and January 4, 2025, subject to the Reporting Person continuing as a service provider through each such date. /s/ David D. O'Toole 2022-01-05